News
Pfizer, BioNTech and COVID-19 vaccine
Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.
Pfizer agreed to an upfront payment of US$1.25 billion, US$150 million for mainland rights and a US$100 million equity ...
Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...
21hon MSN
A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...
Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...
Explore more
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results